Re:mRNA's next challenge: Will it work as a drug?
by rolph on Friday December 18, 2020 @03:38PM
(#25471633)
there is a system homologous to machine learning 2factor authentication.
in very loose terms both keys must be presented while the immune system is in training, the instances where protiens are expressed with out cell surface recognition molecules in proximity are invalid thus foriegn, and memory immunity to this "failed login" is maintained. when both factors [protien plus recognition] are present constituitively over the course of development the immune response is squelched.
in very loose terms both keys must be presented while the immune system is in training, the instances where protiens are expressed with out cell surface recognition molecules in proximity are invalid thus foriegn, and memory immunity to this "failed login" is maintained. when both factors [protien plus recognition] are present constituitively over the course of development the immune response is squelched.
this is known as central tolerance.
https://en.wikipedia.org/wiki/Central_tolerance